Found: 46
Select item for more details and to access through your institution.
Towards treatments for VEXAS.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 804, doi. 10.1111/bjh.17930
- By:
- Publication type:
- Article
First report of novel heterozygous WRAP53 p.Ala522Glyfs*8 mutation associated dyskeratosis congenita.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. e27, doi. 10.1111/bjh.17883
- By:
- Publication type:
- Article
Richter transformation of chronic lymphocytic leukaemia: a British Society for Haematology Good Practice Paper.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 864, doi. 10.1111/bjh.17882
- By:
- Publication type:
- Article
Serological response following BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccination in haematopoietic stem cell transplantation patients.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 928, doi. 10.1111/bjh.17873
- By:
- Publication type:
- Article
Cell erythroid maturation approach: a new paradigm in the road map towards a cure for β‐thalassaemia syndromes.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 806, doi. 10.1111/bjh.17948
- Publication type:
- Article
Erratum.
- Published in:
- 2022
- Publication type:
- Correction Notice
Unusual pattern of thrombotic events in young adult non‐critically ill patients with COVID‐19 may result from an undiagnosed inherited and acquired form of thrombophilia.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 902, doi. 10.1111/bjh.17986
- By:
- Publication type:
- Article
Long‐term efficacy of first‐line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 947, doi. 10.1111/bjh.17984
- By:
- Publication type:
- Article
Perinatal outcomes in women with sickle cell disease: a matched cohort study from London, UK.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1069, doi. 10.1111/bjh.17983
- By:
- Publication type:
- Article
Childhood aggressive B‐cell non‐Hodgkin lymphoma in low–middle‐income countries.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 849, doi. 10.1111/bjh.17979
- By:
- Publication type:
- Article
Significance of anti‐HBc serological status in primary immune thrombocytopenia.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1086, doi. 10.1111/bjh.17977
- By:
- Publication type:
- Article
A roadmap for better management for synovitis in haemophilia.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 812, doi. 10.1111/bjh.17967
- Publication type:
- Article
Differences in the prevalence of mental health disorders among Black American adults with sickle cell disease compared to those with non‐heritable medical conditions or no medical conditions.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1059, doi. 10.1111/bjh.17962
- By:
- Publication type:
- Article
GELAD chemotherapy with sandwiched radiotherapy for patients with newly diagnosed stage IE/IIE natural killer/T‐cell lymphoma: a prospective multicentre study.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 939, doi. 10.1111/bjh.17960
- By:
- Publication type:
- Article
Outcome predictors for maternal red blood cell alloimmunisation with anti‐K and anti‐D managed with intrauterine blood transfusion.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1096, doi. 10.1111/bjh.17956
- By:
- Publication type:
- Article
Effectiveness of COVID‐19 vaccination in patients after allogeneic haematopoietic cell transplant: how much protection are we getting?
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 809, doi. 10.1111/bjh.17955
- By:
- Publication type:
- Article
Longitudinal assessment of adhesion to vascular cell adhesion molecule‐1 at steady state and during vaso‐occlusive crises in sickle cell disease.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1052, doi. 10.1111/bjh.17954
- By:
- Publication type:
- Article
Donor activating killer cell immunoglobulin‐like receptors genes correlated with Epstein–Barr virus reactivation after haploidentical haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1007, doi. 10.1111/bjh.17950
- By:
- Publication type:
- Article
Mimics of Erdheim–Chester disease.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 984, doi. 10.1111/bjh.17949
- By:
- Publication type:
- Article
Interleukin‐1 receptor antagonism leads to improved anaemia in a murine model of sickle cell disease and is associated with reduced ex vivo platelet‐mediated erythrocyte sickling.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1040, doi. 10.1111/bjh.17941
- By:
- Publication type:
- Article
Enhanced clot lysis by a single point mutation in a reteplase variant.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1076, doi. 10.1111/bjh.17942
- By:
- Publication type:
- Article
Dexamethasone‐mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 995, doi. 10.1111/bjh.17940
- By:
- Publication type:
- Article
Long‐term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high‐risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party‐EBMT.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1018, doi. 10.1111/bjh.17939
- By:
- Publication type:
- Article
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 892, doi. 10.1111/bjh.17937
- By:
- Publication type:
- Article
Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 975, doi. 10.1111/bjh.17932
- By:
- Publication type:
- Article
Red blood cell transfusion‐induced non‐transferrin‐bound iron promotes Pseudomonas aeruginosa biofilms in human sera and mortality in catheterized mice.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1105, doi. 10.1111/bjh.17934
- By:
- Publication type:
- Article
Can ruxolitinib avert splenectomy in patients with thalassaemia: a short term case series.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1111, doi. 10.1111/bjh.17871
- By:
- Publication type:
- Article
The clinical landscape of chronic graft‐versus‐host disease management in 2021.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 830, doi. 10.1111/bjh.17835
- By:
- Publication type:
- Article
Identification of patients at high risk of secondary extramedullary multiple myeloma development.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 954, doi. 10.1111/bjh.17925
- By:
- Publication type:
- Article
Prospective validation of the provisional entity of refractory cytopenia of childhood, proposed by the World Health Organization.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1031, doi. 10.1111/bjh.17921
- By:
- Publication type:
- Article
Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 871, doi. 10.1111/bjh.17919
- By:
- Publication type:
- Article
Immunogenicity and safety of the BNT162b2 mRNA COVID‐19 vaccine in haematopoietic stem cell transplantation recipients.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 884, doi. 10.1111/bjh.17918
- By:
- Publication type:
- Article
Erythrophagocytosis in a patient with myelodysplastic syndrome with excess blasts‐1 with isolated del(6q).
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 803, doi. 10.1111/bjh.17913
- By:
- Publication type:
- Article
Severe cutis laxa caused by immunoglobulin M gammopathy.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 802, doi. 10.1111/bjh.17912
- By:
- Publication type:
- Article
Microgranular variant of acute promyelocytic leukaemia with an unusual T/myeloid immunophenotype resembling that of mixed‐phenotype acute leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 801, doi. 10.1111/bjh.17908
- By:
- Publication type:
- Article
Comparative study of therapy‐related and de novo adult b‐cell acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 963, doi. 10.1111/bjh.17906
- By:
- Publication type:
- Article
Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. e33, doi. 10.1111/bjh.17903
- By:
- Publication type:
- Article
3q21 deletion affects GATA2 and is associated with myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1120, doi. 10.1111/bjh.17902
- By:
- Publication type:
- Article
Clinical trial participation improves survival outcomes by increasing availability of new therapeutic agents in multiple myeloma.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1117, doi. 10.1111/bjh.17898
- By:
- Publication type:
- Article
Population‐based cohort study of the efficacy of brentuximab vedotin in relapsed systemic anaplastic large‐cell lymphoma using Public Health England data.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 932, doi. 10.1111/bjh.17896
- By:
- Publication type:
- Article
Azacitidine for patients with Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 969, doi. 10.1111/bjh.17893
- By:
- Publication type:
- Article
Rituximab, lenalidomide, and ibrutinib in relapsed/refractory primary cutaneous diffuse large B‐cell lymphoma, leg type.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. e30, doi. 10.1111/bjh.17886
- By:
- Publication type:
- Article
Divergent impacts of tocilizumab and colchicine in COVID‐19‐associated coagulopathy: the role of alpha‐defensins.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 923, doi. 10.1111/bjh.17885
- By:
- Publication type:
- Article
CD4<sup>+</sup> T cells from patients with glucocorticoid‐refractory immune thrombocytopenia have altered cytokine expression.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1113, doi. 10.1111/bjh.17884
- By:
- Publication type:
- Article
Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes?
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 814, doi. 10.1111/bjh.17811
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 795, doi. 10.1111/bjh.17586
- Publication type:
- Article